Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...

British nurse Lucy Letby to appeal conviction for attempting to kill a baby Former British nurse and convicted child serial ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

An environmental and consumer organization has filed a lawsuit challenging Tyson Foods' claims that its industrial meat production will reach "net-zero" gr… ...

Famotidine is available in over-the-counter (OTC) and prescription strengths. Brand-name versions include Pepcid, Pepcid AC, and Zantac 360. The Food and Drug Administration (FDA) has approved OTC ...